Further support to the importance in epileptic disorders of the ligand-receptor interaction between LGI1 and ADAM22/23 comes from a recent study showing that these interactions are specifically impaired by LGI1 autoantibodies from the sera of patients with limbic encephalitis, which is characterized by amnesia and seizures [28]. This evidence concerns the gene LGI1 and amnesia.